PubRank

F H Sarkar

Author PubWeight™ 86.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995 3.69
2 MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer 2012 1.90
3 Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. Proc Natl Acad Sci U S A 1984 1.86
4 Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001 1.71
5 Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999 1.50
6 Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001 1.43
7 Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer 1999 1.26
8 Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 1994 1.22
9 Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 1998 1.22
10 Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer. Pancreas 2000 1.20
11 p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst 1997 1.19
12 Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells. Proc Natl Acad Sci U S A 1984 1.18
13 Interferon receptors. Cross-linking of human leukocyte interferon alpha-2 to its receptor on human cells. J Biol Chem 1982 1.17
14 Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radic Biol Med 2001 1.13
15 bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. Cancer Res 1995 1.13
16 Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents. Pancreas 1998 1.11
17 Zinc activates NF-kappaB in HUT-78 cells. J Lab Clin Med 2001 1.10
18 Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma. Hum Pathol 2001 1.05
19 Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat 1998 1.03
20 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res 2000 1.01
21 Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr Cancer 1998 1.01
22 Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma. Int J Pancreatol 1997 1.00
23 MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy. Oncogene 2010 1.00
24 Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res 2001 0.99
25 Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus. Pancreas 1998 0.97
26 An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies. Clin Cancer Res 1998 0.96
27 Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int J Oncol 1999 0.95
28 Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther 1998 0.95
29 p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer 1999 0.95
30 Clonal analysis of gliomas. Hum Pathol 1997 0.93
31 Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells. Oncogene 2000 0.93
32 Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia. Breast Cancer Res Treat 1997 0.93
33 Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun 1997 0.92
34 Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obes Rev 2011 0.92
35 Cellular interactions in the hormonal induction of alpha 2u-globulin in rat liver. J Endocrinol 1986 0.90
36 Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer 1999 0.90
37 Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope 1999 0.89
38 Comparisons of several biological and physicochemical properties of human leukocyte interferons produced my human leukocytes and by E. coli. Gene 1980 0.89
39 HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival. Pancreas 1997 0.88
40 Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. Cell Death Dis 2013 0.88
41 Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF. Prostate 1993 0.87
42 Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clin Cancer Res 2001 0.87
43 Inhibition of prostate specific antigen expression by genistein in prostate cancer cells. Int J Oncol 2000 0.87
44 Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod Pathol 1995 0.87
45 Induction of apoptosis in breast cancer cells by TPA. Oncogene 1998 0.86
46 Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer. Histol Histopathol 2007 0.86
47 Increased expression of EGFR in gastric mucosa of aged rats. Am J Physiol 1997 0.85
48 Interferon receptor interaction. Internalization of interferon alpha 2 and modulation of its receptor on human cells. Eur J Biochem 1984 0.85
49 Genistein elicits pleiotropic molecular effects on head and neck cancer cells. Clin Cancer Res 2001 0.84
50 Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol 2000 0.84
51 p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: a molecular and immunohistochemical analysis. Pathol Res Pract 1999 0.83
52 Molecular effects of taxol and caffeine on pancreatic cancer cells. Int J Mol Med 1999 0.83
53 Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol 1997 0.82
54 MicroRNAs in personalized cancer therapy. Clin Genet 2014 0.82
55 Coinage metal complexes against breast cancer. Curr Med Chem 2012 0.82
56 Genetic markers as prognostic indicators in breast cancer. Cancer 1992 0.82
57 Perspectives on medicinal properties of mangiferin. Mini Rev Med Chem 2012 0.82
58 Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma. Int J Pancreatol 1997 0.81
59 The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma. Cancer 1997 0.81
60 Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma. Diagn Mol Pathol 1997 0.81
61 Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol. Clin Cancer Res 2000 0.81
62 Sex-independent synthesis of alpha 2u-globulin and its messenger ribonucleic acid in the rat preputial gland: biochemical and immunocytochemical analyses. Endocrinology 1987 0.81
63 BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome. Genes Chromosomes Cancer 1995 0.80
64 Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Diagn Mol Pathol 1996 0.80
65 Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma. Pancreas 2002 0.80
66 Molecular analysis of the p53 gene in pancreatic adenocarcinoma. Diagn Mol Pathol 1998 0.80
67 Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines. Am J Physiol 1999 0.80
68 Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma. J Cell Physiol 1996 0.79
69 Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy. J Hepatobiliary Pancreat Surg 1998 0.79
70 Current concepts in pancreatic cancer: symposium summary. Pancreas 1998 0.78
71 Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine. Int J Mol Med 1999 0.78
72 Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma. Pancreas 1999 0.78
73 Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study. Cancer 1994 0.78
74 The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease. Ann N Y Acad Sci 2002 0.78
75 Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology. Mod Pathol 1992 0.77
76 The effect of genistein supplementation on performance and antioxidant status of Japanese quail under heat stress. Arch Anim Nutr 2004 0.77
77 Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma. Prostate Cancer Prostatic Dis 2006 0.77
78 Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma. Pancreas 1999 0.77
79 Androgenic regulation of hepatic gene expression. J Steroid Biochem 1987 0.77
80 Effect of electric shock on serotonin (5 HT) content in different organs of rat. Experientia 1977 0.77
81 HPV detection by polymerase chain reaction (PCR) in verrucous lesions of the upper aerodigestive tract. Mod Pathol 1991 0.77
82 Response of adrenal gland to whole body 60Co irradiation. Indian J Exp Biol 1977 0.77
83 Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma. Pancreas 1999 0.76
84 Receptors for human alpha interferon: are gangliosides involved? J Interferon Res 1984 0.76
85 Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. Mod Pathol 1998 0.76
86 Blood platelet monoamine oxidase and acetylcholinesterase in thyrotoxicosis. Indian J Med Res 1980 0.76
87 Purification and immunochemical characterization of the cytoplasmic androgen-binding protein of rat liver. Biochemistry 1989 0.76
88 Premalignant lesions of the upper aerodigestive tract: biomarkers of genetic alterations, proliferation, and differentiation. J Cell Biochem Suppl 1993 0.75
89 Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma. J Urol 2001 0.75
90 A c-erbB-2 promoter-specific nuclear matrix protein from human breast tumor tissues mediates NF-kappaB DNA binding activity. J Biol Chem 1997 0.75
91 Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast. Arch Pathol Lab Med 1993 0.75
92 Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model. Anticancer Drugs 2001 0.75
93 Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol. Int J Oncol 2000 0.75
94 Theory and methodology of evaluating genetic alterations. Diagn Cytopathol 1994 0.75
95 Advances in the diagnosis of urothelial neoplasia. Henry Ford Hosp Med J 1989 0.75
96 Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors. Anal Quant Cytol Histol 1991 0.75
97 Pharmacokinetic comparison of leukocyte and Escherichia coli-derived human interferon type alpha. Antiviral Res 1982 0.75
98 Role of cytodifferentiation and cell-cell communication in the androgen dependent expression of alpha 2u globulin gene in rat liver. Prog Clin Biol Res 1986 0.75
99 Detection of M-bcr/abl fusion by fluorescence in situ hybridization (FISH) in a case of Ph negative CML. Cancer Genet Cytogenet 1995 0.75
100 Concurrent abnormal expression of ERBB-2, EGFR, and p53 genes and clinical disease progression of breast carcinoma. Breast Cancer Res Treat 1993 0.75
101 Immunohistologic analysis of invasive phenotype in breast carcinoma. A clinicopathologic study. Pathol Res Pract 1993 0.75
102 Radiolabeling of human leukocyte and immune interferons with 125I and lactoperoxidase. Methods Enzymol 1986 0.75
103 Responses of brain bioamines and its enzymes to cobalt-60 irradiation. Strahlentherapie 1978 0.75
104 Inhibition of interferon secretion in human fibroblast by vinblastine. Arch Virol 1982 0.75
105 Remodelling of adult cardiac muscle cells in culture: dynamic process of disorganization and reorganization of myofibrils. J Muscle Res Cell Motil 1996 0.75
106 Growth of human nondiploid primary prostate tumor epithelial cells in vitro. Cancer Res 1997 0.75
107 Altered 5-HT metabolism under the influence of 5,6-dihydroxytryptamine in rats. Indian J Exp Biol 1980 0.75
108 Four multiple primary malignant neoplasms of the aerodigestive tract. Ann Thorac Surg 1998 0.75
109 CD95-related apoptotic machinery is functional in pancreatic cancer cells. Pancreas 2001 0.75
110 Effect of a chemical radioprotector administered before irradiation on thyroid, testis and pituitary. Indian J Med Res 1978 0.75
111 On the inhibition of interferon action by inhibitors of fatty acid cyclooxygenase. Virology 1982 0.75
112 Changes in blood serotonin in experimental intestinal obstruction in dogs. Indian J Exp Biol 1977 0.75
113 Prevalence of HPV 16 and 18 DNA sequences in CIN III lesions of adults and adolescents. Diagn Cytopathol 1994 0.75
114 Molecular genetic analysis in the pathologic evaluation of solid tumors: theory and practice. J Clin Lab Anal 1997 0.75
115 Pattern of blood 5-HT changes in gastrointestinal resection in dogs. Indian J Exp Biol 1980 0.75
116 Mouse interferon messenger RNA: characterization of the Xenopus laevis oocyte translation product. Arch Biochem Biophys 1982 0.75
117 Characteristics of spontaneously produced and of virus-induced human LuKII cell interferons. Arch Virol 1983 0.75